When Plans Change: Surgical Implantation of a Transcatheter Pulmonary Valve in Hypoplastic Left Heart Syndrome - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

When Plans Change: Surgical Implantation of a Transcatheter Pulmonary Valve in Hypoplastic Left Heart Syndrome

  • By

  • November 16, 2026

  • 6 min

Share

Objective:

The article examines the objective, findings, and clinical context described in When Plans Change: Surgical Implantation of a Transcatheter Pulmonary Valve in Hypoplastic Left Heart Syndrome.

Approach:
  • Clinical course: A term neonate with HLHS, pulmonary overcirculation and worsening clinical status received pulmonary blood flow restrictors and later required VA-ECMO. New pulmonary regurgitation was associated with a pulmonary valve leaflet defect.
  • Operative strategy: At 10 days of age, intraoperative discovery of an irreparable avulsion of the left pulmonary cusp led the team to replace the valve with a surgically implanted, shortened 22-mm Melody transcatheter valve.
  • Follow-up: The valve was used as a bridge to decision-making, not as definitive Stage I palliation. The patient later underwent PDA stenting, and catheterization assessed valve position and function.
Key Findings:
  • Postoperative echocardiography showed mildly decreased right ventricular function, with no stenosis, regurgitation, paravalvular leak or right ventricular outflow tract obstruction.
  • The patient was successfully decannulated from VA-ECMO.
  • Subsequent catheterization confirmed a well-seated valve without stenosis or regurgitation.
  • In the cited Pediatric Cardiac Care Consortium data, 12 of 3,807 patients with single-ventricle physiology had semilunar valve replacement; none underwent replacement before Stage I palliation or by open surgical approach.
Interpretation:

The authors report that surgical placement of a transcatheter pulmonary valve was technically feasible in this neonate and served as a short-term stabilizing strategy while the team considered longer-term options.

Limitations:
  • This is a single case report and does not establish comparative safety or effectiveness.
  • The approach was described as a short-term solution, not definitive repair.
  • The authors identify risks including right ventricular outflow tract obstruction, coronary compression and aortic root compromise; single-ventricle physiology may limit tolerance of hemodynamic compromise.
Conclusion:

The team used surgical Melody valve implantation after pulmonary cusp avulsion made repair infeasible, preserving future treatment options while the patient’s overall condition was assessed.

Sources:

Original Source(s)

Related Content